Promoter Variants in Tissue Inhibitor of Metalloproteinase-3 (TIMP-3) Protect Against Susceptibility in Pigeon Breeders' Disease

Overview

Journal Thorax

Date 2004 Jun 30

PMID 15223866

Citations 6

Authors

M R Hill

L Briggs

M M Montano

A Estrada

G J Laurent

M Selman

A Pardo

Affiliations

Soon will be listed here.

Abstract

Background: Tissue inhibitors of metalloproteinases (TIMPs) play a major role in extracellular matrix turnover in the lung. However, in chronic lung disorders such as idiopathic pulmonary fibrosis (IPF) and pigeon breeders' disease (PBD), TIMPs may promote an adverse non-degradative environment. We hypothesised that polymorphisms in TIMP-3 could affect susceptibility to IPF and PBD.

Methods: Two promoter variants, -915A>G and -1296T>C, were genotyped in 323 healthy subjects, 94 subjects with IPF, 115 with PBD, and 90 exposed to avian antigen but without PBD. The severity of fibrosis in lung tissue and the clinical outcome after 1 year was determined in the PBD group.

Results: The variants did not influence susceptibility to IPF, but the rare alleles of both variants appeared to be protective against susceptibility to PBD (odds ratio (OR) for carriage of at least one rare allele from either variant 0.48, 95% CI 0.30 to 0.76, p = 0.002). Haplotype analysis of positions -915 and -1296 estimated four haplotypes: *A*T, *G*T, *A*C and *G*C, respectively. Their frequencies differed overall between subjects with PBD and healthy subjects (p = 0.0049) and this was attributable primarily to the *G*C haplotype (OR 0.53, 95% CI 0.36 to 0.77, p = 0.001). The severity of fibrosis correlated with poorer outcome in the PBD group (r = 0.73, p<0.01) but no relationship was seen between the *G*C haplotype and outcome or fibrosis. However, PBD subjects with the *G*C haplotype did have proportionally fewer lymphocytes in their bronchoalveolar fluid than those with the common *A*T haplotype (p = 0.029).

Conclusions: TIMP-3 variants appear to contribute to susceptibility to PBD. This may be through the inflammatory reaction rather than the fibrotic reaction.

Citing Articles

Hypersensitivity pneumonitis.

Costabel U, Miyazaki Y, Pardo A, Koschel D, Bonella F, Spagnolo P Nat Rev Dis Primers. 2020; 6(1):65.

PMID: 32764620 DOI: 10.1038/s41572-020-0191-z.

Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline.

Raghu G, Remy-Jardin M, Ryerson C, Myers J, Kreuter M, Vasakova M Am J Respir Crit Care Med. 2020; 202(3):e36-e69.

PMID: 32706311 PMC: 7397797. DOI: 10.1164/rccm.202005-2032ST.

Effects of tetrandrine combined with acetylcysteine on exercise tolerance, pulmonary function and serum TNF-β1 and MMP-7 in silicosis patients.

Zhang J, Wang Y, Zhang S, Li J, Fang H Exp Ther Med. 2020; 19(3):2195-2201.

PMID: 32104284 PMC: 7027229. DOI: 10.3892/etm.2020.8431.

Genetic variability of T cell responses in hypersensitivity pneumonitis identified using the BXD genetic reference panel.

Wang J, Yoon T, Read R, Yi A, Williams R, Fitzpatrick E Am J Physiol Lung Cell Mol Physiol. 2020; 318(4):L631-L643.

PMID: 31940220 PMC: 7191482. DOI: 10.1152/ajplung.00120.2019.

Translational research in pulmonary fibrosis.

Mathai S, Schwartz D Transl Res. 2019; 209:1-13.

PMID: 30768925 PMC: 9977489. DOI: 10.1016/j.trsl.2019.02.001.

References

Pardo A, Barrios R, Gaxiola M, Carrillo G, Estrada A, Mejia M . Increase of lung neutrophils in hypersensitivity pneumonitis is associated with lung fibrosis. Am J Respir Crit Care Med. 2000; 161(5):1698-704. DOI: 10.1164/ajrccm.161.5.9907065. View

Nagase H, Woessner Jr J . Matrix metalloproteinases. J Biol Chem. 1999; 274(31):21491-4. DOI: 10.1074/jbc.274.31.21491. View

Beranek M, Kankova K, Muzik J . Identification of novel common polymorphisms in the promoter region of the TIMP-3 gene in Czech population. Mol Cell Probes. 2000; 14(4):265-8. DOI: 10.1006/mcpr.2000.0315. View

Yu W, Yu S, Meng Q, Brew K, Woessner Jr J . TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix. J Biol Chem. 2000; 275(40):31226-32. DOI: 10.1074/jbc.M000907200. View

Ye S . Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol. 2000; 19(7):623-9. DOI: 10.1016/s0945-053x(00)00102-5. View

Selman M, King T, Pardo A . Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med. 2001; 134(2):136-51. DOI: 10.7326/0003-4819-134-2-200101160-00015. View

Stephens M, Smith N, Donnelly P . A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001; 68(4):978-89. PMC: 1275651. DOI: 10.1086/319501. View

Kashiwagi M, Tortorella M, Nagase H, Brew K . TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5). J Biol Chem. 2001; 276(16):12501-4. DOI: 10.1074/jbc.C000848200. View

Camarena A, Juarez A, Mejia M, Estrada A, Carrillo G, Falfan R . Major histocompatibility complex and tumor necrosis factor-alpha polymorphisms in pigeon breeder's disease. Am J Respir Crit Care Med. 2001; 163(7):1528-33. DOI: 10.1164/ajrccm.163.7.2004023. View

10.

Leco K, Waterhouse P, Sanchez O, Gowing K, Poole A, Wakeham A . Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J Clin Invest. 2001; 108(6):817-29. PMC: 200926. DOI: 10.1172/JCI12067. View

11.

Hirano K, Sakamoto T, Uchida Y, Morishima Y, Masuyama K, Ishii Y . Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease. Eur Respir J. 2002; 18(5):748-52. DOI: 10.1183/09031936.01.00102101. View

12.

Osman M, Tortorella M, Londei M, Quaratino S . Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases define the migratory characteristics of human monocyte-derived dendritic cells. Immunology. 2002; 105(1):73-82. PMC: 1782644. DOI: 10.1046/j.0019-2805.2001.01349.x. View

13.

Bond M, Murphy G, Bennett M, Newby A, Baker A . Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent type II apoptotic pathway. J Biol Chem. 2002; 277(16):13787-95. DOI: 10.1074/jbc.M111507200. View

14.

Zuo F, Kaminski N, Eugui E, Allard J, Yakhini Z, Ben-Dor A . Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci U S A. 2002; 99(9):6292-7. PMC: 122942. DOI: 10.1073/pnas.092134099. View

15.

Davis R, Thomas M, Cameron J, St John T, Scherer S, Padgett R . Rapid DNA isolations for enzymatic and hybridization analysis. Methods Enzymol. 1980; 65(1):404-11. DOI: 10.1016/s0076-6879(80)65051-4. View

16.

Selman M, Montano M, Ramos C, Chapela R . Concentration, biosynthesis and degradation of collagen in idiopathic pulmonary fibrosis. Thorax. 1986; 41(5):355-9. PMC: 1020626. DOI: 10.1136/thx.41.5.355. View

17.

Montano M, Ramos C, Gonzalez G, Vadillo F, Pardo A, Selman M . Lung collagenase inhibitors and spontaneous and latent collagenase activity in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis. Chest. 1989; 96(5):1115-9. DOI: 10.1378/chest.96.5.1115. View

18.

Tiret L, Amouyel P, Rakotovao R, Cambien F, Ducimetiere P . Testing for association between disease and linked marker loci: a log-linear-model analysis. Am J Hum Genet. 1991; 48(5):926-34. PMC: 1683048. View

19.

CHERNIACK R, Colby T, Flint A, Thurlbeck W, Waldron J, Ackerson L . Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. The BAL Cooperative Group Steering Committee. Am Rev Respir Dis. 1991; 144(4):892-900. DOI: 10.1164/ajrccm/144.4.892. View

20.

Perez-Padilla R, Salas J, Chapela R, Sanchez M, Carrillo G, Perez R . Mortality in Mexican patients with chronic pigeon breeder's lung compared with those with usual interstitial pneumonia. Am Rev Respir Dis. 1993; 148(1):49-53. DOI: 10.1164/ajrccm/148.1.49. View